Literature DB >> 30218395

Electroencephalogram (EEG) for children with autism spectrum disorder: evidential considerations for routine screening.

Ronald J Swatzyna1, Nash N Boutros2, Ann C Genovese3, Erin K MacInerney4, Alexandra J Roark4, Gerald P Kozlowski5.   

Abstract

Routine electroencephalograms (EEG) are not recommended as a screen for epileptic discharges (EDs) in current practice guidelines for children with autism spectrum disorder (ASD). However, a review of the research from the last three decades suggests that this practice should be reevaluated. The significant comorbidity between epilepsy and ASD, its shared biological pathways, risk for developmental regression, and cognitive challenges demand increased clinical investigation requiring a proactive approach. This review highlights and explains the need for screening EEGs for children with ASD. EEG would assist in differentiating EDs from core features of ASD and could be included in a comprehensive assessment. EEG also meets the demand for evidence-based precision medicine and focused care for the individual, especially when overlapping processes of development are present.

Entities:  

Keywords:  Autism spectrum disorder (ASD); Electroencephalography (EEG); Epilepsy; Epileptic discharges; Evidence-based medicine; Screening

Mesh:

Year:  2018        PMID: 30218395     DOI: 10.1007/s00787-018-1225-x

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  4 in total

Review 1.  Motor networks in children with autism spectrum disorder: a systematic review on EEG studies.

Authors:  Jin Bo; Frantzy Acluche; Patricia C Lasutschinkow; Alyssa Augustiniak; Noelle Ditchfield; Renee Lajiness-O'Neill
Journal:  Exp Brain Res       Date:  2022-10-19       Impact factor: 2.064

Review 2.  Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD).

Authors:  Ann Genovese; Merlin G Butler
Journal:  Int J Mol Sci       Date:  2020-07-02       Impact factor: 5.923

Review 3.  Inhibiting Epileptiform Activity in Cognitive Disorders: Possibilities for a Novel Therapeutic Approach.

Authors:  Andras Attila Horvath; Emoke Anna Csernus; Sara Lality; Rafal M Kaminski; Anita Kamondi
Journal:  Front Neurosci       Date:  2020-10-15       Impact factor: 4.677

4.  Potential Cross Talk between Autism Risk Genes and Neurovascular Molecules: A Pilot Study on Impact of Blood Brain Barrier Integrity.

Authors:  Rekha Jagadapillai; Xiaolu Qiu; Kshama Ojha; Zhu Li; Ayman El-Baz; Shipu Zou; Evelyne Gozal; Gregory N Barnes
Journal:  Cells       Date:  2022-07-15       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.